EDAP TMS S.A. - AMERIC

EDAP Reports Third Quarter 2021 Results and Provides Operational Update

17 Nov 2021 16:35:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021

10 Nov 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program

28 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Presentation of Multiple Abstracts Favorably Comparing HIFU to Surgery at the American Urological Association 2021 Annual Meeting

14 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP to Participate at Upcoming Investor Conferences

07 Sep 2021 16:35:00 By Nasdaq GlobeNewswire

EDAP Reports Second Quarter 2021 Results and Provides Operational Update

25 Aug 2021 16:35:00 By Nasdaq GlobeNewswire

EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results

04 Aug 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Issues Letter to Shareholders

20 Jul 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary

15 Jun 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Reports First Quarter 2021 Results and Provides Operational Update

11 May 2021 16:30:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021

04 May 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Pricing of Follow-On Offering

23 Apr 2021 02:30:00 By Nasdaq GlobeNewswire

EDAP Announces Launch of Follow-On Offering

22 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update

30 Mar 2021 16:35:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021

23 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US   

03 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year

20 Jan 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 Jan 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery

14 Jan 2021 08:00:00 By Nasdaq GlobeNewswire

EDAP Issues Letter to Shareholders

06 Jan 2021 08:00:00 By Nasdaq GlobeNewswire